Literature DB >> 20733112

Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Matthew C Riddle1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20733112      PMCID： PMC2980502          DOI： 10.1161/CIRCULATIONAHA.110.960138

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  11 in total

1.  Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use.

Authors:  Graham P Leese; Jixian Wang; Janice Broomhall; Paul Kelly; Andrew Marsden; William Morrison; Brian M Frier; Andrew D Morris
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

2.  Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study.

Authors:  Timothy M E Davis; Simon G A Brown; Ian G Jacobs; Max Bulsara; David G Bruce; Wendy A Davis
Journal:  J Clin Endocrinol Metab       Date:  2010-03-19       Impact factor: 5.958

3.  Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.

Authors:  Scott A Segel; Deanna S Paramore; Philip E Cryer
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

4.  Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring.

Authors:  Cyrus Desouza; Holger Salazar; Benjamin Cheong; Joseph Murgo; Vivian Fonseca
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

5.  Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.

Authors:  Matthew C Riddle; Walter T Ambrosius; David J Brillon; John B Buse; Robert P Byington; Robert M Cohen; David C Goff; Saul Malozowski; Karen L Margolis; Jeffrey L Probstfield; Adrian Schnall; Elizabeth R Seaquist
Journal:  Diabetes Care       Date:  2010-05       Impact factor: 19.112

6.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

7.  The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.

Authors:  Denise E Bonds; Michael E Miller; Richard M Bergenstal; John B Buse; Robert P Byington; Jeff A Cutler; R James Dudl; Faramarz Ismail-Beigi; Angela R Kimel; Byron Hoogwerf; Karen R Horowitz; Peter J Savage; Elizabeth R Seaquist; Debra L Simmons; William I Sivitz; Joann M Speril-Hillen; Mary Ellen Sweeney
Journal:  BMJ       Date:  2010-01-08

8.  Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia.

Authors:  Erwin C Puente; Julie Silverstein; Adam J Bree; Daniel R Musikantow; David F Wozniak; Susan Maloney; Dorit Daphna-Iken; Simon J Fisher
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461

9.  Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors:  Jorge Calles-Escandón; Laura C Lovato; Denise G Simons-Morton; David M Kendall; Rodica Pop-Busui; Robert M Cohen; Denise E Bonds; Vivian A Fonseca; Faramarz Ismail-Beigi; Mary Ann Banerji; Alan Failor; Bruce Hamilton
Journal:  Diabetes Care       Date:  2010-01-26       Impact factor: 17.152

10.  The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.

Authors:  Michael E Miller; Denise E Bonds; Hertzel C Gerstein; Elizabeth R Seaquist; Richard M Bergenstal; Jorge Calles-Escandon; R Dale Childress; Timothy E Craven; Robert M Cuddihy; George Dailey; Mark N Feinglos; Farmarz Ismail-Beigi; Joe F Largay; Patrick J O'Connor; Terri Paul; Peter J Savage; Ulrich K Schubart; Ajay Sood; Saul Genuth
Journal:  BMJ       Date:  2010-01-08
View more
  36 in total

Review 1.  Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT.

Authors:  Toni Terry; Kalyani Raravikar; Nalurporn Chokrungvaranon; Peter D Reaven
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

Review 2.  Glycemic control and weight reduction without causing hypoglycemia: the case for continued safe aggressive care of patients with type 2 diabetes mellitus and avoidance of therapeutic inertia.

Authors:  Stanley S Schwartz; Benjamin A Kohl
Journal:  Mayo Clin Proc       Date:  2010-11-24       Impact factor: 7.616

3.  Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering.

Authors:  Daniel F Berenson; Allison R Weiss; Zhu-Li Wan; Michael A Weiss
Journal:  Ann N Y Acad Sci       Date:  2012-03-13       Impact factor: 5.691

4.  Need for Outcome Scenario Analysis of Clinical Trials in Diabetes.

Authors:  Rosa Garcia-Verdugo; Michael Erbach; Oliver Schnell
Journal:  J Diabetes Sci Technol       Date:  2016-10-05

5.  Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein O-GlcNAc Modification.

Authors:  Yabing Chen; Xinyang Zhao; Hui Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-29       Impact factor: 8.311

Review 6.  Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research.

Authors:  Benjamin M Leon; Thomas M Maddox
Journal:  World J Diabetes       Date:  2015-10-10

Review 7.  Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.

Authors:  Benedict J Maliakkal
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

8.  Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk.

Authors:  Henning Jansen; Christina Loley; Wolfgang Lieb; Michael J Pencina; Christopher P Nelson; Sekar Kathiresan; Gina M Peloso; Benjamin F Voight; Muredach P Reilly; Themistocles L Assimes; Eric Boerwinkle; Christian Hengstenberg; Reijo Laaksonen; Ruth McPherson; Robert Roberts; Unnur Thorsteinsdottir; Annette Peters; Christian Gieger; Rajesh Rawal; John R Thompson; Inke R König; Ramachandran S Vasan; Jeanette Erdmann; Nilesh J Samani; Heribert Schunkert
Journal:  Atherosclerosis       Date:  2015-06-03       Impact factor: 5.162

9.  The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.

Authors:  M Lind; M Olsson; A Rosengren; A-M Svensson; I Bounias; S Gudbjörnsdottir
Journal:  Diabetologia       Date:  2012-08-16       Impact factor: 10.122

10.  A zebrafish model of diabetes mellitus and metabolic memory.

Authors:  Robert V Intine; Ansgar S Olsen; Michael P Sarras
Journal:  J Vis Exp       Date:  2013-02-28       Impact factor: 1.355
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.